Skip to content
Recalls · Brand

Otsuka Pharmaceutical Development & Commercialization, Inc. recalls

Every recall we track for Otsuka Pharmaceutical Development & Commercialization, Inc. — 2 in all, all from 2018 — plus the complaints and injury reports the public filed about them.

2recalls

Recalls per year, by danger level

2 recalls since 2017.

2017: 0 recalls20172018: 2 recalls — 1 lower risk, 1 not yet rated220182019: 0 recalls20192020: 0 recalls20202021: 0 recalls20212022: 0 recalls20222023: 0 recalls20232024: 0 recalls20242025: 0 recalls20252026 (to date): 0 recalls2026to date

All FDA recall records for Otsuka Pharmaceutical Development & Commercialization, Inc. since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.

Recalls per year for Otsuka Pharmaceutical Development & Commercialization, Inc., by danger level
YearStop using nowUse cautionLower riskNot yet ratedTotal
201700000
201800112
201900000
202000000
202100000
202200000
202300000
202400000
202500000
2026 (to date)00000

What to do if you have a recalled Otsuka Pharmaceutical Development & Commercialization, Inc. product

  1. Match the NDC and lot number on your bottle or box to the recall.
  2. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
  3. Report side effects to FDA MedWatch.

See this week’s new recalls.

All Otsuka Pharmaceutical Development & Commercialization, Inc. recalls

1 shown

Otsuka Pharmaceutical Development & Commercialization, Inc. recall questions

How many recalls has Otsuka Pharmaceutical Development & Commercialization, Inc. had?

2 recalls from Otsuka Pharmaceutical Development & Commercialization, Inc. are on record with U.S. safety agencies, from 2018.

What is the most recent Otsuka Pharmaceutical Development & Commercialization, Inc. recall?

Otsuka Pharmaceutical Development & Commercialization, Inc. recalls treatNOW ABILIFY (aripiprazole) / ABILIFY MAINTENA 400-mg (aripiprazole) for extended release injectable suspension., dated Sep 17, 2018. Every Otsuka Pharmaceutical Development & Commercialization, Inc. recall is listed on this page, newest first.

What should I do if I have a recalled Otsuka Pharmaceutical Development & Commercialization, Inc. product?

Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.

How do I get alerts for new Otsuka Pharmaceutical Development & Commercialization, Inc. recalls?

Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.